Who are Rxsight's investors?

Rxsight's investors include Flying L Partners, Foresite Capital, H.I.G. Capital, H.I.G. HealthBridge Partners, Longitude Capital, RA Capital, Visionary Ventures.

How much funding has Rxsight raised?

Rxsight has disclosed $62.7M raised across 2 rounds.

Where is Rxsight headquartered?

Rxsight is headquartered in Pasadena, US.

Rxsight

NASDAQ: RXST

Pasadena, US · Incorporated in Delaware · 7 known investors

rxsight.com ↗

RxSight develops the Light Adjustable Lens (LAL), an FDA-approved intraocular lens that surgeons can adjust after cataract surgery to fine-tune a patient's prescription once the eye has healed. The company's monofocal lens targets cataract surgery and vision correction, including astigmatism as low as 0.50 D.

HealthtechMedical Devices

Founders & leadership

Joseph DevivoNamed on SEC filing

James N. AdlerNamed on SEC filing

Robert H. GrubbsNamed on SEC filing

Werner F. WolfenNamed on SEC filing

D. Verne SharmaNamed on SEC filing

Javier Perez-SalaNamed on SEC filing

Richard DrinkwardNamed on SEC filing

Jan BonelNamed on SEC filing

Daniel M. SchwartzNamed on SEC filing

Investors · 7

Flying L Partners

Foresite CapitalLarkspur

H.I.G. CapitalMiami

H.I.G. HealthBridge PartnersMiami · $5M – $40M

Longitude CapitalMenlo Park · $10M – $30M

RA CapitalBoston

Visionary VenturesNewport Beach · $5M – $15M

Reported raises · per SEC filings

Form D private placements

$62.7M disclosed across 2 rounds · 2012–2017

▶$50MraisedApr 2017 · 62 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

William LinkDirector
Juliet BakkerDirector
J. Andy CorleyDirector
Shelley ThunenExecutive Officer
Ron KurtzExecutive Officer, Director
Dan SchwartzDirector
Bruce RobertsonDirector
Chris CoxDirector
Werner WolfenDirector

Offering amount: $77.5M
Amount sold: $50M
First sale: Feb 2017
Incorporated: Corporation, California
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$12.7MraisedMar 2014 · 45 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Joseph DevivoDirector
James N. AdlerDirector
Robert H. GrubbsDirector
Werner F. WolfenDirector
D. Verne SharmaExecutive Officer, Director
Javier Perez-SalaDirector
Richard DrinkwardExecutive Officer
Jan BonelDirector
Daniel M. SchwartzDirector

Offering amount: $47M
Amount sold: $12.7M
Minimum investment: $50K
Sales commissions: $450K
Proceeds to insiders: $467.5K
Placement agents: Piper Jaffray & Co., Brockett Tamny & Co., Incorporated
First sale: Oct 2012
Incorporated: Corporation, California
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Rxsight do?: RxSight develops the Light Adjustable Lens (LAL), an FDA-approved intraocular lens that surgeons can adjust after cataract surgery to fine-tune a patient's prescription once the eye has healed. The company's monofocal lens targets cataract surgery and vision correction, including astigmatism as low as 0.50 D.
Who are Rxsight's investors?: Rxsight's investors include Flying L Partners, Foresite Capital, H.I.G. Capital, H.I.G. HealthBridge Partners, Longitude Capital, RA Capital, Visionary Ventures.
How much funding has Rxsight raised?: Rxsight has disclosed $62.7M raised across 2 rounds.
Where is Rxsight headquartered?: Rxsight is headquartered in Pasadena, US.